Brynne A Sullivan1, Aneesha Panda2, Aaron Wallman-Stokes3, Rakesh Sahni4, Karen D Fairchild1, Jason G Newland5, Christopher C McPherson2, Zachary A Vesoulis2. 1. Division of Neonatology, Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Virginia. 2. Division of Newborn Medicine, Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri. 3. Division of Neonatology, Department of Pediatrics, Larner College of Medicine at University of Vermont, Burlington, Vermont. 4. Division of Neonatology, Department of Pediatrics, Columbia University Irving Medical Center, New York, New York. 5. Division of Pediatric Infectious Diseases, Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri.
Abstract
BACKGROUND: Antibiotics are widely used in very low-birth-weight infants (VLBW, <1500 g), and excess exposure, particularly to broad-spectrum antibiotics, is associated with significant morbidity. An antibiotic spectrum index (ASI) quantifies antibiotic exposure by relative antimicrobial activity, adding information to exposure measured by days of therapy (DOT). We compared ASI and DOT across multiple centers to evaluate differences in antibiotic exposures. METHODS: We extracted data from patients admitted to 3 level-4 NICUs for 2 years at 2 sites and for 1 year at a third site. We calculated the ASI per antibiotic days and DOT per patient days for all admitted VLBW infants <32 weeks gestational age. Clinical variables were compared as percentages or as days per 1,000 patient days. We used Kruskal-Wallis tests to compare continuous variables across the 3 sites. RESULTS: Demographics were similar for the 734 VLBW infants included. The site with the highest DOT per patient days had the lowest ASI per antibiotic days and the site with the highest mortality and infection rates had the highest ASI per antibiotic days. Antibiotic utilization varied by center, particularly for choice of broad-spectrum coverage, although the organisms causing infection were similar. CONCLUSION: An antibiotic spectrum index identified differences in prescribing practice patterns among 3 NICUs unique from those identified by standard antibiotic use metrics. Site differences in infection rates and unit practices or guidelines for prescribing antibiotics were reflected in the ASI. This comparison uncovered opportunities to improve antibiotic stewardship and demonstrates the utility of this metric for comparing antibiotic exposures among NICU populations.
BACKGROUND: Antibiotics are widely used in very low-birth-weight infants (VLBW, <1500 g), and excess exposure, particularly to broad-spectrum antibiotics, is associated with significant morbidity. An antibiotic spectrum index (ASI) quantifies antibiotic exposure by relative antimicrobial activity, adding information to exposure measured by days of therapy (DOT). We compared ASI and DOT across multiple centers to evaluate differences in antibiotic exposures. METHODS: We extracted data from patients admitted to 3 level-4 NICUs for 2 years at 2 sites and for 1 year at a third site. We calculated the ASI per antibiotic days and DOT per patient days for all admitted VLBW infants <32 weeks gestational age. Clinical variables were compared as percentages or as days per 1,000 patient days. We used Kruskal-Wallis tests to compare continuous variables across the 3 sites. RESULTS: Demographics were similar for the 734 VLBW infants included. The site with the highest DOT per patient days had the lowest ASI per antibiotic days and the site with the highest mortality and infection rates had the highest ASI per antibiotic days. Antibiotic utilization varied by center, particularly for choice of broad-spectrum coverage, although the organisms causing infection were similar. CONCLUSION: An antibiotic spectrum index identified differences in prescribing practice patterns among 3 NICUs unique from those identified by standard antibiotic use metrics. Site differences in infection rates and unit practices or guidelines for prescribing antibiotics were reflected in the ASI. This comparison uncovered opportunities to improve antibiotic stewardship and demonstrates the utility of this metric for comparing antibiotic exposures among NICU populations.
Authors: Katharina L van Santen; Jonathan R Edwards; Amy K Webb; Lori A Pollack; Erin O'Leary; Melinda M Neuhauser; Arjun Srinivasan; Daniel A Pollock Journal: Clin Infect Dis Date: 2018-07-02 Impact factor: 9.079
Authors: Dustin D Flannery; Erik Brandsma; Judy Saslow; Amy B Mackley; David A Paul; Zubair H Aghai Journal: J Matern Fetal Neonatal Med Date: 2017-12-20
Authors: Joseph Y Ting; Anne Synnes; Ashley Roberts; Akhil Deshpandey; Kimberly Dow; Eugene W Yoon; Kyong-Soon Lee; Simon Dobson; Shoo K Lee; Prakesh S Shah Journal: JAMA Pediatr Date: 2016-12-01 Impact factor: 16.193
Authors: Lorry G Rubin; Pablo J Sánchez; Jane Siegel; Gail Levine; Lisa Saiman; William R Jarvis Journal: Pediatrics Date: 2002-10 Impact factor: 7.124
Authors: Luisa F Gomez-Arango; Helen L Barrett; H David McIntyre; Leonie K Callaway; Mark Morrison; Marloes Dekker Nitert Journal: Sci Rep Date: 2017-02-27 Impact factor: 4.379
Authors: Dustin D Flannery; Rachael K Ross; Sagori Mukhopadhyay; Alison C Tribble; Karen M Puopolo; Jeffrey S Gerber Journal: JAMA Netw Open Date: 2018-05-18